Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 213 Myelodysplastic Syndromes 82 Leukemia 44 Leukemia, Myelomonocytic, Chronic 35 Recurrence 16 Myeloproliferative Disorders 15 Neoplasm, Residual 10 Lymphoma, T-Cell, Peripheral 10 Leukemia, Biphenotypic, Acute 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Myelodysplastic-Myeloproliferative Diseases 7 Lymphoma, Large B-Cell, Diffuse 7 Anemia, Refractory, with Excess of Blasts 7 Primary Myelofibrosis 6 Lymphoma, Non-Hodgkin 6 Hodgkin Disease 6 Congenital Abnormalities 6 Lymphoma, T-Cell 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Leukemia, Monocytic, Acute 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Hematologic Neoplasms 5 Polycythemia Vera 4 Pancreatic Neoplasms 4 Multiple Myeloma 4 Lymphoma, Follicular 4 Lymphoma, Extranodal NK-T-Cell 4 Leukemia, Myeloid 4

Interventions

Radiosurgery 113 Temozolomide 104 Bevacizumab 70 Radiotherapy 66 Magnetic Resonance Spectroscopy 66 Carboplatin 29 pembrolizumab 27 Irinotecan 26 Surgical Procedures, Operative 25 Nivolumab 23 Radiation 22 Etoposide 22 Magnetic Resonance Imaging 21 Ipilimumab 21 Erlotinib Hydrochloride 21 Cyclophosphamide 21 Surveys and Questionnaires 19 Aminolevulinic Acid 18 Specimen Handling 16 Pemetrexed 16 Mental Status and Dementia Tests 16 Cisplatin 16 Carmustine 15 Topotecan 14 Trastuzumab 13 Saline Solution 12 Neuropsychological Tests 12 Gefitinib 11 Filgrastim 11 Drug Therapy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Brain Neoplasms × Azacitidine × Clear all

NCT02940483 2018-11-30

5-AZA

The University of Texas Health Science Center, Houston

Phase EARLY_PHASE1 Completed

Brain Neoplasms, Ependymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡